• Health & Medicine

Three breast cancer relapse tests recommended for NHS use

Three tests designed to predict if breast cancer will come back after treatment have been recommended for use on the NHS. Three tests designed to predict if breast cancer will come back after treatment have been recommended for use on the NHS.

20 December 2018

• Health & Medicine

The new Cancer Drugs Fund has quietly reached a significant milestone

A revamped Cancer Drugs Fund is giving patients new options and renewed chances of successful treatment, quicker than ever before. A revamped Cancer Drugs Fund is giving patients new options and renewed chances of successful treatment, quicker than ever before.

14 December 2018

• Health & Medicine

Immunotherapy combo not approved for advanced kidney cancer patients on the NHS

People with a certain type of advanced kidney cancer will not be able to have a combination of two immunotherapy drugs on the NHS in England. People with a certain type of advanced kidney cancer will not be able to have a combination of two immunotherapy drugs on the NHS in England.

13 December 2018

• Health & Medicine

Immunotherapy drug made available for some NHS patients with advanced skin cancer after surgery

An immunotherapy drug will be made available to some patients with advanced melanoma skin cancer on the NHS in England. An immunotherapy drug will be made available to some patients with advanced melanoma skin cancer on the NHS in England.

30 November 2018

• Health & Medicine

Immunotherapy drug to be made available for some NHS patients with advanced skin cancer

Some patients with advanced skin cancer will now have access to immunotherapy after surgery on the NHS in England. Some patients with advanced skin cancer will now have access to immunotherapy after surgery on the NHS in England.

21 November 2018

• Health & Medicine

Targeted drug could extend lives of some women with advanced breast cancer

Combining a targeted drug with hormone therapy could extend survival for some women with advanced breast cancer, according to new trial results. Combining a targeted drug with hormone therapy could extend survival for some women with advanced breast cancer, according to new trial results.

23 October 2018

• Health & Medicine

Immunotherapy trial shows promise for some women with an aggressive breast cancer

An immunotherapy drug has shown promise for the first time in a form of aggressive breast cancer. An immunotherapy drug has shown promise for the first time in a form of aggressive breast cancer.

23 October 2018

• Health & Medicine

Prostate cancer radiotherapy could have benefits even after the disease has spread

Trial finds prostate radiotherapy plus standard treatment improves survival for some men whose prostate cancer has spread, which could help thousands in the UK. Trial finds prostate radiotherapy plus standard treatment improves survival for some men whose prostate cancer has spread, which could help thousands in the UK.

21 October 2018

• Health & Medicine

Cancer trial shows treating the prostate with radiotherapy improves survival

Treating the prostate with radiotherapy alongside standard treatment led to a 11 per cent* increase in survival for some men with advanced prostate cancer. Treating the prostate with radiotherapy alongside standard treatment led to a 11 per cent* increase in survival for some men with advanced prostate cancer.

21 October 2018

• Health & Medicine

Nobel Prize 2018: how the winning chemistry technique helped generate new cancer treatments

Professor George Smith and Sir Gregory Winter won a Nobel Prize for a developing a technique that can help scientists discover new cancer drugs. Professor George Smith and Sir Gregory Winter won a Nobel Prize for a developing a technique that can help scientists discover new cancer drugs.

17 October 2018

• Health & Medicine

‘Cutting edge’ CAR T cell immunotherapy approved in England. But is the NHS ready?

With two complex CAR T immunotherapies now approved on the NHS in England, we look at how the health service has had to react to these exciting new treatments. With two complex CAR T immunotherapies now approved on the NHS in England, we look at how the health service has had to react to these exciting new treatments.

5 October 2018

• Health & Medicine

NHS England to fund engineered cell therapy for adults with aggressive lymphoma

A cancer immunotherapy will be offered on the NHS in England to some adults with aggressive non-Hodgkin lymphoma, NHS England announced today. A cancer immunotherapy will be offered on the NHS in England to some adults with aggressive non-Hodgkin lymphoma, NHS England announced today.

5 October 2018